Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocugen, Inc. - Common Stock (NQ:OCGN)

1.130 -0.070 (-5.83%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
34 35 Next >
Earnings Scheduled For February 28, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter. 
Via Benzinga
More Likely to 5x First: Novavax vs. Ocugen
They skyrocketed before. It could happen again. 
Via The Motley Fool
1 Reason to Buy Ocugen in 2023 and 2 Reasons to Sell
Ocugen has recently broadened its pipeline. 
Via The Motley Fool
Ocugen Announces Encouraging Data From Late-Stage COVID-19 Vaccine Study
Via Benzinga
Ocugen, Inc. Announces Submission of Investigational New Drug Application with U.S. FDA to Initiate a Phase 1 Clinical Trial Evaluating OCU200 for the Treatment of Diabetic Macular Edema
From Ocugen
Via GlobeNewswire
Ocugen to Present at Retinal Vascular Disease Drug Development Summit
From Ocugen
Via GlobeNewswire
Ocugen to Host Conference Call on Tuesday, February 28 at 8:30 A.M. ET to Discuss Business Updates and Fourth Quarter and Full Year 2022 Financial Results
From Ocugen
Via GlobeNewswire
Why Shares of Ocugen Jumped Thursday
Could short-sellers be enacting a squeeze? 
Via The Motley Fool
Stocks That Hit 52-Week Lows On Monday
  On Monday, 42 companies hit new 52-week lows. 
Via Benzinga
7 Heavily Shorted Penny Stocks for Your Short-Squeeze Watch List
Here are seven heavily shorted penny stocks that can potentially witness a sharp reversal rally in the foreseeable future. 
Via InvestorPlace
Ocugen Appoints Quan A. Vu as Chief Business Officer
From Ocugen
Via GlobeNewswire
Ocugen, Inc. to Present at 2023 BIO CEO & Investor Conference
From Ocugen
Via GlobeNewswire
2 Struggling Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague
Two of these stocks have what it takes to rebound and deliver lasting gains. 
Via The Motley Fool
Why GeneDx Holdings Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket
Gainers Freightos Limited (NASDAQ: CRGO) shares rose 69.2% to $17.75 in pre-market trading. Freightos listed on the Nasdaq following merger with special purpose acquisition company, Gesher I... 
Via Benzinga
3 of the Fastest-Growing Stocks on the Planet in 2023
These hypergrowth stocks are expected to deliver up to 1,075% sales growth this year. 
Via The Motley Fool
3 Under-the-Radar Stocks With 590% to 772% Upside in 2023, According to Wall Street
Select analysts expect these small-caps stocks to catapult higher in the new year. 
Via The Motley Fool
7 ‘Loser’ Stocks to Short for Big Profits
These stocks to short can generate significant profits for investors, as they are all tremendously overvalued at this point. 
Via InvestorPlace
Exclusive: Top 10 Most Searched Tickers On Benzinga Pro In 2022 — Where Do SPY, Tesla, Apple And AMC Rank?
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a leading source for traders to see the latest news on the overall market and individual tickers all in one... 
Via Benzinga
Why Is Party City (PRTY) Stock Up 41% Today?
Party City (PRTY) stock is in the news Monday as investors prepare for the celebration goods company to file for bankruptcy. 
Via InvestorPlace
Why Is Ocugen (OCGN) Stock Up Today?
Ocugen is hoping its Indian-made inactivated Covid-19 shot can provide a low-cost boost for those previously given MRNA-based vaccines. 
Via InvestorPlace
Tesla's Delivery Wait Times Go Up, China Wants To Secure License For Generic Version Of Pfizer's Paxlovid, India-Made iPhone Exports Surpass $2.5B: Today's Top Stories
Bloomberg 
Via Benzinga
Ocugen Announces Positive Top-Line Data for COVID-19 Vaccine Candidate COVAXIN™ (BBV152) in Phase 2/3 Immuno-bridging and Broadening Study: Both Co-primary Endpoints Met
From Ocugen
Via GlobeNewswire
7 Hot Meme Stocks of 2022 to Sell Before 2023
The value of most of the meme stocks have plunged, but there are still many meme stocks to sell at this point. 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 298 companies achieved new lows for the year. 
Via Benzinga
Why Is Agrify (AGFY) Stock Down 50% Today?
Agrify (AGFY) stock is on the move Friday as the company's shares take a beating after revealing details of a stock offering. 
Via InvestorPlace
OCGN Stock Alert: What to Know About Ocugen’s Latest Phase 3 Clinical Trial
OCGN stock fell into the red despite Ocugen's success in advancing a regenerative cell therapy product evaluation. 
Via InvestorPlace
Ocugen Announces Phase 3 Confirmatory Clinical Trial Agreement for NeoCart®
Important next step for Ocugen’s regenerative cell therapy in orthopedics since announcing pipeline expansion in May 2022 
From Ocugen
Via GlobeNewswire
Ocugen, Inc. to Ring the Nasdaq Stock Market Closing Bell
From Ocugen
Via GlobeNewswire
7 Tech Stocks to Sell Before They Topple in 2023
It's much harder now than in 2021 to find tech stocks to sell, but some tech names are still dramatically overvalued. 
Via InvestorPlace
Ocugen Announces Update on OCU400 Phase 1/2 Clinical Trial Targeting Retinitis Pigmentosa and Leber Congenital Amaurosis
From Ocugen
Via GlobeNewswire
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.